PAION AG Logo

PAION AG

Developed drugs for hospital-based sedation, anesthesia, and critical care.

PA8 | F

Overview

Corporate Details

ISIN(s):
DE000A3E5EG5
LEI:
529900CGHB9UWY40BU45
Country:
Germany
Address:
Heussstraße 25, 52078 Aachen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PAION AG was a specialty pharmaceutical company focused on developing and commercializing innovative drugs for hospital-based applications, including sedation, anesthesia, and critical care. The company aimed to address unmet medical needs in both outpatient and hospital settings. Effective January 1, 2024, insolvency proceedings were opened over the company's assets, and the sale of its business operations was finalized in March 2024.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-09-29 00:00
Interim Report
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.0…
German 163.2 KB
2023-09-29 00:00
Interim Report
Half-yearly financial report 2023
English 699.3 KB
2023-09-27 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
German 5.7 KB
2023-09-27 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
German 5.7 KB
2023-06-07 00:00
Annual Report
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 879.5 KB
2023-06-01 00:00
Regulatory News Service
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 931.2 KB
2023-06-01 00:00
Regulatory News Service
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 533.1 KB
2023-05-31 00:00
Annual Report
Annual financial report 2022
English 1.8 MB
2023-05-22 00:00
Earnings Release
Q1 statement / Q1 financial report 2023
English 200.9 KB
2023-05-17 00:00
Annual Report
English 1.6 MB
2023-05-15 00:00
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
German 5.7 KB
2023-05-15 00:00
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
German 5.7 KB
2022-11-17 00:00
Earnings Release
Q3 statement / Q3 financial report 2022
English 110.5 KB
2022-09-05 00:00
Interim Report
Half-yearly financial report 2022
German 518.2 KB
2022-08-31 00:00
Interim Report
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
German 167.2 KB

Automate Your Workflow. Get a real-time feed of all PAION AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PAION AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-12-27 Siebert, Gregor Board Buy None 24,110.26 EUR
2022-12-22 Dieckow, StB Simone Close relation Buy None 500,000.00 EUR
2022-12-22 Fuchs, Anna-Louisa Close relation Other None N/A
2022-12-21 Zeitfracht GmbH & Co. KGaA Close relation Buy None 3,607,500.00 EUR

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
Cellid Co., Ltd. Logo
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
South Korea 299660

Talk to a Data Expert

Have a question? We'll get back to you promptly.